FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...

Detailed price information for Fennec Pharmaceuticals Inc (FRX-T) from The Globe and Mail including charting and trades.

Manulife today introduced a refreshed strategy featuring new and elevated strategic priorities that build on its strengths and are anchored in an ambition to be the number one choice for customers.